Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Postdoctoral Research Assistant Yiyan Zheng has won one of three prizes for best poster presentations.

Yiyan Zheng

Postdoctoral Research Assistant Yiyan Zheng, who works in Professor Ahmed's Ovarian Cancer Cell Laboratory, has one one of three prizes at the EMBO International Conference on Microtubules.  

This award is for Yiyan’s work on FER kinase as a potential therapeutic target in ovarian cancer to enhance the efficacy of the chemotherapeutic drug taxol on microtubules. Yiyan won this prize in competition with more than 270 scientists.

The prize has special significance as the conference coincided with the 50th anniversary for the discovery of tubulin, the building block of microtubules.

Yiyan’s work has been funded by Target Ovarian Cancer (

Similar stories

Singula Bio provides new hope for cancer with diverse, individualised therapies


The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer.

Understanding the origins of ovarian cancer


Research into the early detection of ovarian cancer by the Ahmed group, receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust.

MitOX 2017 - 1st December

Cancer Reproductive Medicine & Genetics Research

The Nuffield Department of Obstetrics & Gynaecology invites you to MitOX 2017 - an annual meeting with talks on mitochondrial genetics, physiology, neurosciences and cancer.

Cancer hijacks natural cell process to survive


Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by Professor Ahmed Ahmed at the Nuffield Department of Obstetrics & Gynaecology. This discovery could help clinicians identify and inhibit the process, giving them much better control of a person's cancer.

Cannabinoid biomedicine research programme launched

Cancer Research

Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.